Pure Global
NCT05886621

Testing the Integrated mHealth App Intervention SiS-H

Pilot RCT to Test the Integrated mHealth App Intervention (SiS-H) for Smoking Cessation for People With HIV
Massachusetts General Hospital·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
Smiling instead of Smoking - HIV
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Massachusetts General Hospital
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Oct 01, 2024
Enrollment
64 participants
Primary outcome

App usage

Summary

The present study is a pilot randomized controlled trial (RCT) that seeks to test the
 feasibility, acceptability, process outcomes, and exploratory outcomes of a newly integrated,
 app-based smoking cessation treatment (SiS-H, which stands for Smiling instead of Smoking
 for people with HIV) for people with HIV who smoke. This treatment will be compared to
 onboarding to the National Cancer Institute's smartphone app QuitGuide (QG). Persons with
 HIV who smoke and are engaged in HIV clinical care (n=64) will be randomized (1:1) to smoking
 cessation support via SiS-H vs. QuitGuide.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05886621
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05886621 through Pure Global AI's free database. This phase not specified trial is sponsored by Massachusetts General Hospital and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.